Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons

Pain is a under-recognized association of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) antibodies. Of 147 patients with these autoantibodies, pain was experienced by 17 of 33 (52%) with CASPR2- versus 20 of 108 (19%) with LGI1 antibodies (p = 0.0005), and...

Full description

Bibliographic Details
Main Authors:	Ramanathan, S, Tseng, M, Davies, AJ, Uy, CE, Paneva, S, Mgbachi, VC, Michael, S, Varley, JA, Binks, S, Themistocleous, AC, Fehmi, J, Anziska, Y, Soni, A, Hofer, M, Waters, P, Brilot, F, Dale, RC, Dawes, J, Rinaldi, S, Bennett, DL, Irani, SR
Format:	Journal article
Language:	English
Published:	Wiley 2021

Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons

Similar Items